Pre-made Sirexatamab benchmark antibody ( Whole mAb, anti-DKK1 therapeutic antibody, Anti-SK/DKK-1 Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-694

Pre-Made Sirexatamab biosimilar, Whole mAb, Anti-DKK1 Antibody: Anti-SK/DKK-1 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package List Price(In USD) Discount off Discount Price
GMP-Bios-ab-694-1mg 1mg 3090 Inquiry Inquiry

Size: 1mg | 10mg | 100mg



Description

Products Name (INN Index) Pre-Made Sirexatamab biosimilar, Whole mAb, Anti-DKK1 Antibody: Anti-SK/DKK-1 therapeutic antibody
INN Name Sirexatamab
TargetDKK1
FormatWhole mAb
DerivationHumanized
Species ReactivityHuman
CH1 IsotypeIgG4
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2021
Year Recommendedna
CompaniesLeap Therapeutics
Conditions Approvedna
Conditions ActiveDKK1
Conditions Discontinuedna
Development Techna